• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL NAVITOR TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL NAVITOR TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Catalog Number NVTR-23
Device Problems Off-Label Use (1494); Malposition of Device (2616)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/10/2024
Event Type  malfunction  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that on (b)(6) 2024, a 23mm navitor valve (sn: (b)(6)) was chosen for implant, using a small flexnav delivery system (lot: 8892912) for a transcatheter aortic valve implantation.This was a valve-in-valve procedure where the navitor valve was to be implanted into a previously implanted 21mm non-abbott valved graft.During initial placement of the valve, there was difficulty crossing the aortic arch, but was successful.It was believed to be difficult due to the location where the surgical aortic root valved graft was sewn to the native aorta.The patient had a somewhat tortuous anatomy.Physician proceeded to deploy valve approximately 0-1 mm below the base of the previously implanted surgical valve.High gradient and valve underexpansion were present, so a post balloon aortic valvuloplasty (bav) was performed.The stent frame of the valve became supra annular after balloon expansion due to the stent frame shortening the valve above the annulus as it expanded.Physician decided to snare the valve and implant a second valve.A new 23mm navitor valve (sn: (b)(6)) was prepared with a new small flexnav delivery system (lot: 8684036).Physician continued to have difficulty crossing arch again, which ultimately caused a tear at the anastomosis of the native aorta and graft from aortic root replacement.The valve was deployed in the aortic arch in hopes to seal the tear.Physician requested a third 23mm navitor valve (sn: (b)(6)) and small flexnav delivery system (lot: 8684036) to attempt to seal the tear but was unable to deploy that valve, potentially from the curvature in the valve capsule while trying to deploy in the aortic arch.Team agreed not to open patient¿s chest and subsequently the patient expired on the day of procedure due to bleeding out in the chest cavity.The patient was considered to be extreme risk prior to procedure and was not an open-heart surgery candidate.
 
Manufacturer Narrative
An event of device malposition and off-label use was reported.Information from the field indicated that the valve was deployed in place after a tear in the aortic arch was caused, in hopes of sealing the tear.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on available information, the reported event appears to be related to procedural conditions (attempt to seal tear).Please note per the instructions for use (ifu), "the navitor transcatheter aortic valve implantation system is indicated for relief of aortic stenosis in patient with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a heart team, including a cardiac surgeon, to be high or greater risk for open surgical therapy." as the valve was deployed to attempt to seal a tear in the aortic arch, this is a deviation from the ifu.The deviation from the ifu and its associated potential adverse events will be addressed in the letter requested by the account.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVITOR TRANSCATHETER AORTIC VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18624268
MDR Text Key334498483
Report Number2135147-2024-00452
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P190023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/01/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberNVTR-23
Device Lot Number8959356
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/05/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/06/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
1ST FLEXNAV DS, FNAV-DS-SM, LOT 8892912; 1ST NAVITOR VALVE, NVTR-23, SN (B)(6) ; 2ND FLEXNAV DS, FNAV-DS-SM, LOT 8684036; 2ND NAVITOR VALVE, NVTR-23, SN (B)(6) ; 3RD FLEXNAV DS, FNAV-DS-SM, LOT 8684036; 3RD NAVITOR VALVE, NVTR-23, SN (B)(6)
Patient Age71 YR
Patient SexFemale
Patient Weight57 KG
-
-